Blueprint Medicines Corp’s filing revealed that its CHIEF OPERATING OFFICER Rossi Christina unloaded Company’s shares for reported $0.15 million on Jul 03 ’25. In the deal valued at $128.25 per share,1,172 shares were sold. As a result of this transaction, Rossi Christina now holds 63,546 shares worth roughly $8.22 million.
Then, Carter Percy H. sold 1,051 shares, generating $134,791 in total proceeds. Upon selling the shares at $128.25, the CHIEF SCIENTIFIC OFFICER now owns 53,155 shares.
Before that, Carter Percy H. sold 2,659 shares. Blueprint Medicines Corp shares valued at $340,033 were divested by the CHIEF SCIENTIFIC OFFICER at a price of $127.88 per share. As a result of the transaction, Carter Percy H. now holds 54,206 shares, worth roughly $7.01 million.
Wedbush downgraded its Blueprint Medicines Corp [BPMC] rating to a Neutral from a an Outperform in a research note published recently. Wolfe Research began covering BPMC with “an Outperform” recommendation on March 18, 2025. Jefferies started covering the stock on March 17, 2025. It rated BPMC as “a Buy”.
Price Performance Review of BPMC
On Friday, Blueprint Medicines Corp [NASDAQ:BPMC] saw its stock fall -0.02% to $129.3. Over the last five days, the stock has gained 0.74%. Blueprint Medicines Corp shares have risen nearly 12.19% since the year began. Nevertheless, the stocks have risen 48.25% over the past one year. While a 52-week high of $129.49 was reached on 07/10/25, a 52-week low of $73.04 was recorded on 04/09/25.
Levels Of Support And Resistance For BPMC Stock
The 24-hour chart illustrates a support level at 129.08, which if violated will result in even more drops to 128.87. On the upside, there is a resistance level at 129.43. A further resistance level may holdings at 129.57.
How much short interest is there in Blueprint Medicines Corp?
A steep rise in short interest was recorded in Blueprint Medicines Corp stocks on 2025-06-13, dropping by -2.54 million shares to a total of 3.13 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 5.67 million shares. There was a decline of -81.11%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 07, 2025 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $150 price target.
